Results 251 to 260 of about 138,424 (357)

HEPATITIS B SURFACE ANTIGEN IN CIRRHOSIS OF THE LIVER AND PRIMARY LIVER CARCINOMA IN NAGASAKI AREA

, 1977
T Kanda
openalex   +2 more sources

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo, Hui Liu, Yu‐Jing Song, Jian‐Hua Wang, Danfeng Liu, Zhi‐Wei Zheng, Jia‐Jun Li, Boya Li, An Song, Wei He, Lei‐Lei Yang, Shuo Wang   +11 more
wiley   +1 more source

Recombinant Yeast-Based Vaccines: Importance and Applications. [PDF]

Infect Dis Rep
Kumar R.
europepmc   +1 more source

Characterization of the immune response generated by intramuscular administration of nucleocapsid and surface antigens of Hepatitis B

, 2010
Yadira Lobaina, Daymir García, Diane Rodríguez, Yanaisa La O, Julio Aguilar   +4 more
openalex   +1 more source

Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Pembrolizumab, an immune checkpoint inhibitor (ICI), has transformed cancer treatment across various malignancies, including metastatic urothelial cancer. As the use of pembrolizumab becomes increasingly widespread, understanding its potential adverse effects is essential.
Ching‐Cheng Chan, Ming‐Jen Lee, Jian Su, Jen‐Jen Su   +3 more
wiley   +1 more source

A replication-competent deltavirus from the marsupial fat-tailed dunnart <i>Sminthopsis crassicaudata</i>. [PDF]

J Gen Virol
Denis Z, Courgnaud V, de la Peña M, Majzoub K.   +3 more
europepmc   +1 more source

Plant Viral Vectors for Vaccine Development. [PDF]

Vaccines (Basel)
Shahgolzari M, Yavari A, Venkataraman S, Faija M, Hefferon K.   +4 more
europepmc   +1 more source

Higher risk of postpartum phase transition to immune-active among HBeAg-positive pregnant women with indeterminate phase. [PDF]

Front Cell Infect Microbiol
Tang Q, Wang CR, Li H, Chen ZW, Liu XQ, Xue YL, Qiu Y, Cai N, Zeng Y, Hu P.   +9 more
europepmc   +1 more source

Partial Delipidation Improves the T-Cell Antigenicity of Hepatitis B Virus Surface Antigen

, 2006
Isabelle Desombere, A. Willems, Yvonne Gijbels, Geert Leroux‐Roels   +3 more
openalex   +2 more sources

Ten‐Year Follow‐Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT‐II): Improved Clinical Outcome After Combination Therapy

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Chronic delta hepatitis represents a major health burden. Until recently, pegylated interferon‐alfa‐2a (PEG‐IFNα) therapy was the only treatment option for patients infected with hepatitis D virus (HDV). The aim of this study was to evaluate 10‐year long‐term clinical and virological outcomes after 96 weeks of treatment with PEG ...
Cihan Yurdaydin, Julia Kahlhöfer, Florin Alexandru Caruntu, Kendal Yalcin, Selim Gürel, Ulus S. Akarca, Kathrin Sprinzl, Hans H. Bock, Jan‐Hendrik Bockmann, George V. Papatheodoridis, Uta Merle, Münevver Demir, Svenja Hardtke, Onur Keskin, Ramazan Idilman, Markus Cornberg, Heiner Wedemeyer, Anika Wranke   +17 more
wiley   +1 more source